Dr. Lal PathLabs logo

LALPATHLAB - Dr. Lal PathLabs Share Price

₹2266.65 -38.6  -1.7%

Last Trade - 3:55am

Mid Cap
Market Cap £1.86bn
Enterprise Value £1.78bn
Revenue £141.9m
Position in Universe 191st / 3056
Unlock LALPATHLAB Revenue
Relative Strength (%)
1m -5.86%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -12.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
6,596 7,913 9,124 10,569 12,034 13,304 15,502 17,904 +15.1%
+21.5 +36.8 +18.0 +9.8 +15.9 +13.3 +23.5 +22.1
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 31 December 2020, Dr. LalPathLabs Ltd revenues increased 12% to RS11.5B. Net incomeincreased 8% to RS2.08B. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Net income was partiallyoffset by Employee benefit expense increase of 10% toRS1.98B (expense), Selling/General/Admin. Expense increaseof 9% to RS1.46B (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for LALPATHLAB
Graphical History



Net Income


Normalised EPS


PE Ratio Range


Dividend Yield Range

LALPATHLAB Dividend Yield Range Unlock LALPATHLAB Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
Profile Summary

Dr. Lal PathLabs Limited is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of Bio-chemistry, Hematology, Histopathology, Microbiology, Electrophoresis, Immuno-chemistry, Immunology, Virology, Cytology, other pathological and radiological investigations. The Company's geographical segments include India and Outside India. The Company offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of liver, disorders of bone, drugs of abuse, infertility, lymphoma, water purity, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, pregnancy and viral infections. The Company's other offerings include diabetes care program, loyalty card and wellness card.

Last Annual March 31st, 2020
Last Interim December 31st, 2020
Incorporated February 14, 1995
Public Since December 23, 2015
No. of Shareholders: 61,898
No. of Employees: 3,923
Sector Healthcare
Industry Healthcare Providers & Services
Exchange National Stock Exchange of India
Shares in Issue 82,589,451
Free Float (0.0%)
Eligible for
LALPATHLAB Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for LALPATHLAB
Upcoming Events for LALPATHLAB
Frequently Asked Questions for Dr. Lal PathLabs
What is the Dr. Lal PathLabs share price?

As of 3:55am, shares in Dr. Lal PathLabs are trading at ₹2266.65, giving the company a market capitalisation of £1.86bn. This share price information is delayed by 15 minutes.

How has the Dr. Lal PathLabs share price performed this year?

Shares in Dr. Lal PathLabs are currently trading at ₹2266.65 and the price has moved by 40.17% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Dr. Lal PathLabs price has moved by 8.94% over the past year.

What are the analyst and broker recommendations for Dr. Lal PathLabs?

Of the analysts with advisory recommendations for Dr. Lal PathLabs, there are there are currently 1 "buy" , 3 "hold" and 2 "sell" recommendations. The overall consensus recommendation for Dr. Lal PathLabs is Sell. You can view the full broker recommendation list by unlocking its StockReport.

When will Dr. Lal PathLabs next release its financial results?

Dr. Lal PathLabs is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Dr. Lal PathLabs dividend yield?

The Dr. Lal PathLabs dividend yield is 0.52% based on the trailing twelve month period.

Does Dr. Lal PathLabs pay a dividend?

Last year, Dr. Lal PathLabs paid a total dividend of 12, and it currently has a trailing dividend yield of 0.52%. Looking ahead, Dr. Lal PathLabs has not announced an ex-dividend date yet and the next dividend pay date is 2021-02-27.

When does Dr. Lal PathLabs next pay dividends?

Dr. Lal PathLabs has yet to annouce their ex-dividend date and the next dividend pay date is 2021-02-27. The historic dividend yield on Dr. Lal PathLabs shares is currently 0.52%.

How do I buy Dr. Lal PathLabs shares?

To buy shares in Dr. Lal PathLabs you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Dr. Lal PathLabs?

Shares in Dr. Lal PathLabs are currently trading at ₹2266.65, giving the company a market capitalisation of £1.86bn.

Where are Dr. Lal PathLabs shares listed? Where are Dr. Lal PathLabs shares listed?

Here are the trading details for Dr. Lal PathLabs:

Country of listing: India
Exchange: NSI
Ticker Symbol: LALPATHLAB
What kind of share is Dr. Lal PathLabs?

Based on an overall assessment of its quality, value and momentum, Dr. Lal PathLabs is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Dr. Lal PathLabs share price forecast 2021?

Shares in Dr. Lal PathLabs are currently priced at ₹2266.65. At that level they are trading at 5.95% premium to the analyst consensus target price of 0.00.

Analysts covering Dr. Lal PathLabs currently have a consensus Earnings Per Share (EPS) forecast of 33.788 for the next financial year.

How can I tell whether the Dr. Lal PathLabs share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Dr. Lal PathLabs. Over the past six months, the relative strength of its shares against the market has been -5.11%. At the current price of ₹2266.65, shares in Dr. Lal PathLabs are trading at 14.34% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Dr. Lal PathLabs PE Ratio?

The Dr. Lal PathLabs PE ratio based on its reported earnings over the past 12 months is 79.26. The shares are currently trading at ₹2266.65.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Dr. Lal PathLabs?

Dr. Lal PathLabs's management team is headed by:

Arvind Lal - CHM
Om Manchanda - CEO
Vandana Lal - EDR
Rahul Sharma - NED
Anoop Singh - IND
Harneet Chandhoke - IND
Rajat Kalra - CCO
Somya Satsangi - IND
Archana Erdmann - DRC
Who are the major shareholders of Dr. Lal PathLabs?

Here are the top five shareholders of Dr. Lal PathLabs based on the size of their shareholding:

Lal (Arvind) Individual Investor
Percentage owned: 31.98% (26.4m shares)
Lal (Vandana) Individual Investor
Percentage owned: 19.47% (16.1m shares)
WestBridge Capital Partners, LLC Private Equity
Percentage owned: 8.48% (7.00m shares)
Wasatch Advisors Inc Investment Advisor
Percentage owned: 5.09% (4.20m shares)
Stewart Investors Investment Advisor
Percentage owned: 3.05% (2.52m shares)
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.